Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Menopause affects hair and skin; more research needed for treatment.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hair loss in women not always linked to increased oil production; other factors may be involved.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Women with high androgen levels may have more severe COVID-19 symptoms.